Pyxis Group, a global advisory firm serving the commodities industry, together with its joint venture partner Principia ...

While Pyxis Oncology, Inc. (NASDAQ:PYXS) has gained 54.78% year-to-date, analysts continue to see 293.30% upside, helping it ...

However, it's important to note that Pyxis Oncology is not currently profitable, with a negative operating income of $64.37 million in the last twelve months. The company's revenue stands at $16.15 ...

Pyxis Oncology has concluded its first multi-target sublicensing agreement under the new arrangement with a stealth ADC company. This expansion builds on the former agreement, which provided Pyxis ...

Completed target enrollment in Phase 1 monotherapy dose expansion study of MICVO in 2L+ R/M HNSCC in the first quarter of 2026 Updated data from MICVO Phase 1/2 dose escalation study in combination ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

It’s been a good week for investors of Pyxis Oncology (NASDAQ:PYXS), to say the least. Over the past 4 sessions Pyxis shares have gained 170%, bringing the year-to-date haul to a mighty 340%. This ...

Pyxis Tankers ( (PXS)) has shared an update. On April 24, 2026, Pyxis Tankers Inc. reported a planned change in its senior finance leadership, with Chief Financial Officer Henry Williams set to step ...

Pyxis Tankers Inc. (PXS) closed the most recent trading day at $4.05, moving -1.46% from the previous trading session. This change lagged the S&P 500's 0.65% loss on the day. Meanwhile, the Dow gained ...

When the bulk carrier Pyxis Ocean pulled into port after seven months of hauling grain between Europe and South America, the ...

Blackmagic Camera 10.2 makes PDAF official on the PYXIS 6K, with new autofocus transition speed controls and Cloud Streaming ...